This quarter’s e-issue focuses on malaria in pregnancy, a critically important topic within the field of malaria prevention and control. The changes that occur in a woman’s body when she becomes pregnant, and particularly to her immune system, leave her especially vulnerable to contracting malaria, and experiencing severe illness. Read more…
Malaria elimination is possible within a generation. But controlling malaria and eliminating malaria are different, and each pose certain challenges. Overcoming the unique challenges of malaria elimination is essential to meeting this goal, and the barriers presented in malaria elimination settings will require different strategies and policies.
A recent study in PLOS Pathogens investigates how Epstein-Barr virus and malaria co-infection may create a lethal combination if the timing is right.
Two days before delivering his last State of the Union address, President Obama called one of his top advisers into the Oval Office and said he had decided to add a major pledge to the speech that his team had neither discussed nor vetted: to rid the world of malaria… The result was two sentences in his State of the Union address about how, in part through American commitment, the world could soon “end the scourge of H.I.V./AIDS.”
The World Health Organization reported the agency would begin testing a promising malaria vaccine in October to see if it should be used in African countries affected by the parasitic disease.
New research shows how mosquitoes have become so good at finding hosts, like us, for their bloody meals.
The European Federation for Pharmaceutical Sciences (EUFEPS) has awarded the Giorgio Segré Prize to Prof Joel Tarning for his scientific research work on the pharmacokinetic and pharmacodynamic properties of antimalarial drugs in vulnerable populations, such as pregnant women and young children.